Vaccinex Cash Per Share from 2010 to 2024

VCNX Stock  USD 3.69  0.13  3.65%   
Vaccinex Cash Per Share yearly trend continues to be fairly stable with very little volatility. Cash Per Share will likely drop to 3.15 in 2024. During the period from 2010 to 2024, Vaccinex Cash Per Share regression line of annual values had r-squared of  0.000031 and arithmetic mean of  110.06. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
3.31068694
Current Value
3.15
Quarterly Volatility
192.61621125
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Vaccinex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 19.7 K or Depreciation And Amortization of 181 K, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or Days Sales Outstanding of 451. Vaccinex financial statements analysis is a perfect complement when working with Vaccinex Valuation or Volatility modules.
  
Check out the analysis of Vaccinex Correlation against competitors.
For more information on how to buy Vaccinex Stock please use our How to Invest in Vaccinex guide.

Latest Vaccinex's Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Vaccinex over the last few years. It is Vaccinex's Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaccinex's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.27 X10 Years Trend
Very volatile
   Cash Per Share   
       Timeline  

Vaccinex Cash Per Share Regression Statistics

Arithmetic Mean110.06
Geometric Mean51.81
Coefficient Of Variation175.00
Mean Deviation98.03
Median62.76
Standard Deviation192.62
Sample Variance37,101
Range790
R-Value(0.01)
Mean Square Error39,954
R-Squared0.000031
Significance0.98
Slope(0.24)
Total Sum of Squares519,414

Vaccinex Cash Per Share History

2024 3.15
2023 3.31
2022 31.63
2021 62.86
2020 118.44
2019 45.26
2018 792.96

About Vaccinex Financial Statements

Vaccinex investors use historical fundamental indicators, such as Vaccinex's Cash Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaccinex. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Per Share 3.31  3.15 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaccinex Stock Analysis

When running Vaccinex's price analysis, check to measure Vaccinex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaccinex is operating at the current time. Most of Vaccinex's value examination focuses on studying past and present price action to predict the probability of Vaccinex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaccinex's price. Additionally, you may evaluate how the addition of Vaccinex to your portfolios can decrease your overall portfolio volatility.